Literature DB >> 6957262

Glucocorticoid receptors in childhood acute lymphocytic leukemia.

M E Costlow, C H Pui, G V Dahl.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6957262

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  6 in total

1.  Pharmacokinetics of prednisolone in children with acute lymphoblastic leukaemia.

Authors:  I Choonara; J Wheeldon; P Rayner; M Blackburn; I Lewis
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

2.  Glucocorticoid resistance in a multiple myeloma cell line is regulated by a transcription elongation block in the glucocorticoid receptor gene (NR3C1).

Authors:  Beatriz Sánchez-Vega; Varsha Gandhi
Journal:  Br J Haematol       Date:  2008-12-26       Impact factor: 6.998

Review 3.  Glucocorticoid receptors in human leukemias and related diseases.

Authors:  E B Thompson; J R Smith; S Bourgeois; J M Harmon
Journal:  Klin Wochenschr       Date:  1985-08-01

4.  Efficacy of prednisone in refractory multiple myeloma and measurement of glucocorticoid receptors. A Southwest Oncology Group study.

Authors:  V Gupta; E B Thompson; D Stock-Novack; S E Salmon; H I Pierce; J D Bonnet; D Chilton; J Beckford
Journal:  Invest New Drugs       Date:  1994       Impact factor: 3.850

5.  Dexamethasone-resistant human Pre-B leukemia 697 cell line evolving elevation of intracellular glutathione level: an additional resistance mechanism.

Authors:  Hitoshi Inoue; Haruyuki Takemura; Yasukazu Kawai; Akira Yoshida; Takanori Ueda; Toshiyuki Miyashita
Journal:  Jpn J Cancer Res       Date:  2002-05

6.  Selinexor synergizes with dexamethasone to repress mTORC1 signaling and induce multiple myeloma cell death.

Authors:  Christian Argueta; Trinayan Kashyap; Boris Klebanov; Thaddeus J Unger; Cathy Guo; Susie Harrington; Erkan Baloglu; Margaret Lee; William Senapedis; Sharon Shacham; Yosef Landesman
Journal:  Oncotarget       Date:  2018-05-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.